Clinical Trials Browser

OTHER × Esophageal Squamous Cell Carcinoma × tremelimumab × Clear all

Adenocarcinoma Of Esophagus, Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT03377400 2020-12-17

Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer

Phase 2 Unknown

40 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Clinical Trials

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer